133 related articles for article (PubMed ID: 29553968)
41. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results.
Makkat S; Luypaert R; Stadnik T; Bourgain C; Sourbron S; Dujardin M; De Greve J; De Mey J
Radiology; 2008 Nov; 249(2):471-82. PubMed ID: 18780825
[TBL] [Abstract][Full Text] [Related]
42. Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study.
Aimi F; Procopio MG; Alvarez Flores MT; Brouland JP; Piazzon N; Brajkovic S; Dupouy DG; Gijs M; de Leval L
Virchows Arch; 2019 Sep; 475(3):313-323. PubMed ID: 31267199
[TBL] [Abstract][Full Text] [Related]
43. Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens.
Nassar A; Cohen C; Agersborg SS; Zhou W; Lynch KA; Albitar M; Barker EA; Vanderbilt BL; Thompson J; Heyman ER; Lange H; Olson A; Siddiqui MT
Arch Pathol Lab Med; 2011 Jul; 135(7):896-902. PubMed ID: 21732780
[TBL] [Abstract][Full Text] [Related]
44. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
[TBL] [Abstract][Full Text] [Related]
45. Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis.
Kinoe H; Yamanouchi K; Kuba S; Morita M; Sakimura C; Kanetaka K; Takatsuki M; Abe K; Yano H; Matsumoto M; Otsubo R; Hayashida N; Nagayasu T; Eguchi S
J BUON; 2018 Dec; 23(7):60-66. PubMed ID: 30722113
[TBL] [Abstract][Full Text] [Related]
46. Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.
Ekholm M; Grabau D; Bendahl PO; Bergh J; Elmberger G; Olsson H; Russo L; Viale G; Fernö M
Acta Oncol; 2015 Jul; 54(7):1040-8. PubMed ID: 25959664
[TBL] [Abstract][Full Text] [Related]
47. Computer-assisted assessment of the human epidermal growth factor receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls.
Hall BH; Ianosi-Irimie M; Javidian P; Chen W; Ganesan S; Foran DJ
BMC Med Imaging; 2008 Jun; 8():11. PubMed ID: 18534031
[TBL] [Abstract][Full Text] [Related]
48. The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma.
Yildiz-Aktas IZ; Dabbs DJ; Bhargava R
Mod Pathol; 2012 Aug; 25(8):1098-105. PubMed ID: 22460807
[TBL] [Abstract][Full Text] [Related]
49. High Fidelity of Breast Biomarker Metrics: A 10-Year Experience in a Single, Large Academic Institution.
Zhang H; Han M; Varma KR; Clark BZ; Bhargava R; Dabbs DJ
Appl Immunohistochem Mol Morphol; 2018; 26(10):697-700. PubMed ID: 30095467
[TBL] [Abstract][Full Text] [Related]
50. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker.
Liu JJ; Shen R; Chen L; Ye Y; He G; Hua K; Jarjoura D; Nakano T; Ramesh GK; Shapiro CL; Barsky SH; Gao JX
Int J Clin Exp Pathol; 2010 Mar; 3(4):328-37. PubMed ID: 20490325
[TBL] [Abstract][Full Text] [Related]
51. Effect of ASCO/CAP guidelines for determining ER status on molecular subtype.
Deyarmin B; Kane JL; Valente AL; van Laar R; Gallagher C; Shriver CD; Ellsworth RE
Ann Surg Oncol; 2013 Jan; 20(1):87-93. PubMed ID: 22875649
[TBL] [Abstract][Full Text] [Related]
52. [How Long Are Unstained Sections Available for Immunostaining? -A Study of Antigenicity Preservation Time-].
Inoue S; Matsuki Y; Mori M
Rinsho Byori; 2016 Nov; 64(11):1215-1219. PubMed ID: 30695301
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of methods for preserving PTEN antigenicity in stored paraffin sections.
Gelb AB; Freeman VA; Astrow SH
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):569-73. PubMed ID: 21552118
[TBL] [Abstract][Full Text] [Related]
54. [Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay].
Ahr A; Scharl A; Göhring UJ; Crombach G; Stoffl M
Pathologe; 1995 Jul; 16(4):278-84. PubMed ID: 7667210
[TBL] [Abstract][Full Text] [Related]
55. Validation of the Xpert Breast Cancer STRAT 4 Assay on the GeneXpert instrument to Assess Hormone Receptor, Ki67, and HER2 Gene Expression Status in Breast Cancer Tissue Samples.
Sewanywa L; Hale M; Michelow P; Mayne E; Wiggill T
Appl Immunohistochem Mol Morphol; 2023 Oct; 31(9):613-620. PubMed ID: 37800656
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer.
Yoshioka T; Hosoda M; Yamamoto M; Taguchi K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer; 2015 Mar; 22(2):185-91. PubMed ID: 23645542
[TBL] [Abstract][Full Text] [Related]
57. Effect of Surface Decalcification With Hydrochloric Acid on the Determination of Estrogen Receptor, Progesterone Receptor, Ki67, and Human Epidermal Growth Factor Receptor 2 Expressions in Invasive Breast Carcinoma Based on Immunohistochemistry and Fluorescence In Situ Hybridization.
Ping W; Xin R; Li Z; Yupeng C; Fangling S; Caihong R; Shun H; Sheng Z
Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):232-238. PubMed ID: 36883948
[TBL] [Abstract][Full Text] [Related]
58. Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment.
Chebil G; Bendahl PO; Fernö M; ;
Acta Oncol; 2003; 42(1):43-7. PubMed ID: 12665330
[TBL] [Abstract][Full Text] [Related]
59. Allelic imbalance at the HER2/TOP2A locus in breast cancer.
Huijsmans CJ; van den Brule AJ; Rigter H; Poodt J; van der Linden JC; Savelkoul PH; Hilbink M; Hermans MH
Diagn Pathol; 2015 May; 10():56. PubMed ID: 26022247
[TBL] [Abstract][Full Text] [Related]
60. Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice.
Buza N; English DP; Santin AD; Hui P
Mod Pathol; 2013 Dec; 26(12):1605-12. PubMed ID: 23765245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
